Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 2 (2005), Issue 10 (October)

1. Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1.
   J Leukoc Biol, 78(4): 1008-15. [Abstract] [Full-text]
2. The INV(16) cooperates with ARF haploinsuffiency to induce acute myeloid leukemia.
   J Biol Chem. [Abstract] [Full-text]
3. Gefitinib induces myeloid differentiation of acute myeloid leukemia.
   Blood, 106(8): 2841-8. [Abstract] [Full-text]
4. The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis.
   Blood, 106(8): 2646-54. [Abstract] [Full-text]
5. Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia.
   Blood, 106(8): 2854-61. [Abstract] [Full-text]
6. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.
   Blood, 106(8): 2827-36. [Abstract] [Full-text]
7. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.
   Blood, 106(8): 2865-70. [Abstract] [Full-text]
8. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
   Cancer Res, 65(19): 8754-65. [Abstract] [Full-text]
9. High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell Transplantation.
   J Clin Oncol. [Abstract] [Full-text]
10. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
    Clin Cancer Res, 11(19): 7164s-7170s. [Abstract] [Full-text]
11. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
    Clin Cancer Res, 11(19): 6793-9. [Abstract] [Full-text]
12. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.
    Clin Cancer Res, 11(19): 6787-92. [Abstract] [Full-text]
13. The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocation.
    Int J Hematol, 82(3): 210-4. [Abstract] [Full-text]
14. Towards a pathogenesis-oriented therapy of acute myeloid leukemia.
    Crit Rev Oncol Hematol. [Abstract] [Full-text]
15. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents.
    Semin Oncol, 32(5): 511-20. [Abstract] [Full-text]
16. Epigenetic drugs: a longstanding story.
    Semin Oncol, 32(5): 437-42. [Abstract] [Full-text]
17. Essential thrombocythemia.
    Semin Hematol, 42(4): 230-8. [Abstract] [Full-text]
18. Assessment of the downstream portion of the mitochondrial pathway of caspase activation in patients with acute myeloid leukemia.
    Apoptosis. [Abstract] [Full-text]
19. Positive association of farm or rural residence with acute myeloid leukemia incidence in a cohort of older women.
    Cancer Epidemiol Biomarkers Prev, 14(10): 2446-8. [Abstract] [Full-text]
20. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
    Leuk Res. [Abstract] [Full-text]
21. Mutations of the FLT3 gene in adult acute myeloid leukemia: determination of incidence and identification of a novel mutation in a Thai population.
    Cancer Genet Cytogenet, 162(2): 127-34. [Abstract] [Full-text]
22. 3'CBFbeta deletion associated with inv(16) in acute myeloid leukemia.
    Cancer Genet Cytogenet, 162(2): 122-6. [Abstract] [Full-text]
23. Monitoring of minimal residual disease in acute myeloid leukemia.
    Crit Rev Oncol Hematol. [Abstract] [Full-text]
24. Treatment of childhood acute myeloid leukemia.
    Expert Rev Anticancer Ther, 5(5): 917-29. [Abstract] [Full-text]
25. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
    Leukemia. [Abstract] [Full-text]
26. Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation.
    J Biol Chem, 280(42): 35217-27. [Abstract] [Full-text]
27. Obesity in pediatric oncology.
    Pediatr Blood Cancer, 45(7): 881-91. [Abstract] [Full-text]
28. Mutation analysis of SBDS in pediatric acute myeloblastic leukemia.
    Pediatr Blood Cancer, 45(7): 920-4. [Abstract] [Full-text]
29. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Ann Hematol. [Abstract] [Full-text]
30. Role of cyclic AMP response element binding protein in human leukemias.
    Cancer, 104(9): 1819-1824. [Abstract] [Full-text]
31. Detection of various platelet-associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura.
    Cytometry B Clin Cytom, 68(1): 37-42. [Abstract] [Full-text]
32. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Blood, 106(9): 3314-21. [Abstract] [Full-text]
33. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.
    Blood, 106(9): 3150-9. [Abstract] [Full-text]
34. Treatment concepts of acute promyelocytic leukemia.
    Crit Rev Oncol Hematol. [Abstract] [Full-text]
35. The molecular pathogenesis of acute myeloid leukemia.
    Crit Rev Oncol Hematol. [Abstract] [Full-text]
36. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia.
    Leukemia. [Abstract] [Full-text]
37. TNFalpha stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells.
    Leukemia. [Abstract] [Full-text]
38. Role of gamma-glutamyl cysteine synthetase (gamma-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias.
    Clin Chim Acta. [Abstract] [Full-text]
39. Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.
    Cancer, 104(9): 1931-8. [Abstract] [Full-text]
40. Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
    Leukemia, 19(11): 1941-7. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.